— Know what they know.
Not Investment Advice
Also trades as: AGYTF (OTC) · $vol 0M

AGY.L LSE

Allergy Therapeutics plc
1W: +0.0% 1M: -9.5% 3M: -30.4% YTD: -59.4% 1Y: -40.6% 3Y: +66.7% 5Y: -99.8%
£5.00 ($0.07)
+0.24 (+5.04%)
 
Weekly Expected Move ±8.3%
£4 £4 £5 £5 £6
LSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 35 · £300.8M mcap · 745M float · 0.056% daily turnover
#3 of 7
Drug Manufacturers - Specialty & Generic
Healthcare · Small Cap · 6 peers
Market Share
1.7%
Top 4 Concentration: 99.8%

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
AGY.L Allergy Therapeutics plc $300M -4.8 -551.0 -244.2 -54.9 -3.7 1 BEARISH -40.6
STX.L Shield Therapeutics plc $90M -8.0 321.4 2603.7 -7.4 302.1 4 BULLISH -26.5
EAH.L ECO Animal Health Group plc $70M 30.3 4.4 10.0 -0.9 2.0 7 BULLISH 33.6
HIK.L Hikma Pharmaceuticals PLC $4.4B 11.7 31.4 22.1 12.9 15.3 7 BEARISH -14.3
PXS.L Provexis plc $20M -44.8 -83.5 -141.0 -57.9 156.6 2 BEARISH 33.3
ABTI Alterola Biotech, Inc. — -0.1 -27.4 216.7 — — 3 BEARISH 0.0
HLN.L Haleon plc $39B 18.1 9.6 7.4 13.6 -1.3 8 BEARISH -9.4

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

AGY.L vs Benchmarks

ROIC
AGY.L
-244.2
Industry
-0.8
Gross Margin
AGY.L
53.3
Industry
44.9
Op Margin
AGY.L
-32.9
Industry
-19.3
Net Margin
AGY.L
-54.9
Industry
-24.6
Sector
-13.9
Revenue Growth
AGY.L
-3.7
Sector
10.1
P/E Ratio
AGY.L
-4.8
Sector
23.7
ROE
AGY.L
-551.0
Sector
-28.8
Piotroski F
AGY.L
1.0
Sector
4.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms